Tyers Asset Management LLC - AGIOS PHARMACEUTICALS INC ownership

AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 206 filers reported holding AGIOS PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.

Quarter-by-quarter ownership
Tyers Asset Management LLC ownership history of AGIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2019$21,000
+110.0%
656
+215.4%
0.00%
Q2 2019$10,000
-95.3%
208
-93.4%
0.00%
-100.0%
Q1 2019$212,000
+107.8%
3,136
+42.0%
0.01%
+75.0%
Q4 2018$102,000
+1033.3%
2,208
+1871.4%
0.00%
Q3 2018$9,000
-66.7%
112
-65.0%
0.00%
-100.0%
Q2 2018$27,000
+800.0%
320
+900.0%
0.00%
Q1 2018$3,000320.00%
Other shareholders
AGIOS PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
BB BIOTECH AG 2,719,998$155,502,0004.38%
Casdin Capital, LLC 295,000$16,865,0004.11%
Opaleye Management Inc. 130,000$7,432,0002.38%
Opus Point Partners Management, LLC 28,704$1,641,0001.42%
Fernwood Investment Management, LLC 27,550$1,575,0000.84%
Rhenman & Partners Asset Management AB 100,000$5,717,0000.77%
COLUMBIA WANGER ASSET MANAGEMENT LLC 760,116$43,456,0000.65%
Eventide Asset Management 214,000$12,234,0000.64%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 262,984$15,035,0000.59%
CAPITAL GUARDIAN TRUST CO 663,089$37,909,0000.54%
View complete list of AGIOS PHARMACEUTICALS INC shareholders